| Cancer Information Highlights |
| From the National Cancer Institute |
| Updating you about cancer causes, prevention, screening, treatment, coping, and more |
| |
| New from NCI |
| Immunotherapy Improves How Long Some People with Advanced Esophageal Cancer Live |
 |
|
Results from a large clinical trial suggest that some people with advanced esophageal cancer live longer when treated with immunotherapy-based combination therapy. Combining nivolumab (Opdivo) with either another immunotherapy drug or chemotherapy was more effective than the current standard of chemotherapy alone. |
| Don’t Just Talk to Patients, Listen to Them! |
 |
|
Check out Dr. Vanessa Sheppard’s story of survivorship and her work to increase cancer screening and clinical trial participation in underserved communities. |
Should People Over Age 75 Be Screened for Colorectal Cancer?
Screening for colorectal cancer in people aged 45 to 75 has been shown to reduce deaths from the disease. Now, a new study suggests that screening may help some people over age 75. |
| New Immunotherapy Combination for Advanced Melanoma |
 |
|
People with advanced melanoma treated with two immunotherapy drugs—nivolumab (Opdivo) and a new drug called relatlimab—lived longer without their cancer getting worse than those treated only with nivolumab. Learn more about these drugs and the clinical trial that led to these results. |
Head and Neck Cancers
This updated page defines head and neck cancers and explains risk factors, symptoms, diagnosis, treatment, follow-up, and rehabilitation from these cancers. |
Human Papillomavirus (HPV) Vaccines
This updated page defines HPV vaccines and explains who should get them and why vaccination is important. Learn about the safety of these vaccines, how they work against HPV, and if insurance covers them. |
Cell Phones and Cancer Risk
This updated page summarizes the latest research on mobile phones and the risk of cancer. Learn about the type of radiation given off by cell phones and why it is not likely to cause harm.
|
| FDA Approvals |
Avapritinib
We’ve updated our drug summary on avapritinib (Ayvakit) with a recent Food and Drug Administration approval. This drug is now approved to treat adults with an advanced form of a rare blood disorder called systemic mastocytosis. |
|
| |
| Also of Interest |
Immunotherapy to Treat Cancer
Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. Learn about the types of immunotherapy, which cancers are treated with it, and side effects it may cause. |
Contact Us for Help
Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email. |
|
|
|
|
|
